HopeStage
Back to all studies
RecruitingNCT06856161

Blood markers to study depression and schizophrenia

About this titleRead the official source — NCT06856161
Observational studyAges 19+CanadaAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 19 years.

Listed locations
New WestminsterSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 25, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
500
Sponsor
Fraser Health
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
Canada
Age range
Over 19 Years
Official registry ID
NCT06856161
Official title
Show the full official title

A Novel Blood Test as a Differential Diagnosis and Drug Efficacy Biomarker in Mental Health

Recruitment & locations

Currently recruiting

New Westminster

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Fraser Health.

Who can participate?

Listed age limits: from 19 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies